Vaxart, Inc.
VXRTNASDAQHealthcare● Active
$0.60
$-0.02(-3.44%)
Market Cap$144912240
P/E Ratio—
52W High$0.84
52W Low$0.26
Vaxart, Inc.（VXRT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · VXRT · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.24B | $0.03B | $0.01B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.05B |
| Gross Profit | $0.24B | $0.03B | $0.00B | $0.00B | ($0.05B) |
| Gross Margin %(computed) | 100.00% | 100.00% | 39.02% | 100.00% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.20B | $0.07B | $0.07B | $0.08B | $0.05B |
| G&A Expenses | $0.02B | $0.02B | $0.02B | $0.03B | $0.02B |
| Total Operating Expenses | $0.22B | $0.09B | $0.09B | $0.11B | $0.02B |
| Operating Income | $0.02B | ($0.07B) | ($0.08B) | ($0.11B) | ($0.07B) |
| Operating Margin %(computed) | 7.62% | -230.99% | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.02B | ($0.07B) | ($0.08B) | ($0.11B) | ($0.07B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.02B | ($0.07B) | ($0.08B) | ($0.11B) | ($0.07B) |
| Net Margin %(computed) | 6.88% | -233.27% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.07 | $-0.14 | $-0.17 | $-0.22 | $-0.14 |
| Wtd Avg Shares | 0.23B | 0.49B | 0.49B | 0.49B | 0.49B |
| EBITDA | $0.03B | ($0.05B) | ($0.07B) | ($0.10B) | ($0.07B) |
| EBITDA Margin %(computed) | 11.89% | -191.18% | -977.54% | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Vaxart, Inc.
关于Vaxart, Inc.（VXRT）损益表
Vaxart, Inc.（VXRT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，VXRT实现营收$0.24B，毛利润$0.24B（毛利率100.00%），净利润$0.02B（净利率6.88%）。
常见问题
VXRT · 4 问Vaxart, Inc.（VXRT）2025财年营收为$0.24B，同比up726.7%。
VXRT revenueVXRT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09